These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28618262)

  • 1. The Helper T Cell's Dilemma in Tuberculosis.
    Barber DL
    Cell Host Microbe; 2017 Jun; 21(6):655-656. PubMed ID: 28618262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
    Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.
    Moguche AO; Musvosvi M; Penn-Nicholson A; Plumlee CR; Mearns H; Geldenhuys H; Smit E; Abrahams D; Rozot V; Dintwe O; Hoff ST; Kromann I; Ruhwald M; Bang P; Larson RP; Shafiani S; Ma S; Sherman DR; Sette A; Lindestam Arlehamn CS; McKinney DM; Maecker H; Hanekom WA; Hatherill M; Andersen P; Scriba TJ; Urdahl KB
    Cell Host Microbe; 2017 Jun; 21(6):695-706.e5. PubMed ID: 28618268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
    Clemmensen HS; Knudsen NPH; Billeskov R; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Mortensen R
    Front Immunol; 2020; 11():585359. PubMed ID: 33240275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-cell-oriented vaccination against Mycobacterium tuberculosis].
    Nagata T; Koide Y
    Nihon Saikingaku Zasshi; 2010 Dec; 65(2-4):309-24. PubMed ID: 20505270
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
    Riccomi A; Palma C
    PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis.
    Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
    Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
    J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis immunity induced in mice by vaccination with Mycobacterium smegmatis over-expressing Antigen 85B is due to the increased influx of IFNgamma-positive CD4 T cells into the lungs.
    Lindsey DR; Dhandayuthapani S; Jagannath C
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1(Suppl 1):S46-8. PubMed ID: 20006304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
    Dintwe OB; Day CL; Smit E; Nemes E; Gray C; Tameris M; McShane H; Mahomed H; Hanekom WA; Scriba TJ
    Eur J Immunol; 2013 Sep; 43(9):2409-20. PubMed ID: 23737382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
    Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
    J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.
    Luabeya AK; Kagina BM; Tameris MD; Geldenhuys H; Hoff ST; Shi Z; Kromann I; Hatherill M; Mahomed H; Hanekom WA; Andersen P; Scriba TJ; ; Schoeman E; Krohn C; Day CL; Africa H; Makhethe L; Smit E; Brown Y; Suliman S; Hughes EJ; Bang P; Snowden MA; McClain B; Hussey GD
    Vaccine; 2015 Aug; 33(33):4130-40. PubMed ID: 26095509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
    Romano M; Roupie V; Wang XM; Denis O; Jurion F; Adnet PY; Laali R; Huygen K
    Immunology; 2006 Jul; 118(3):321-32. PubMed ID: 16827893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.